Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Traumatic Brain Injury and Neurovascular Disturbances, Neuroscience and Neuropharmacology Research, Traumatic Brain Injury Research, and Neuroinflammation and Neurodegeneration Mechanisms.
Progesterone in Addition to Standard of Care vs Standard of Care Alone in the Treatment of Men Hospitalized With Moderate to Severe COVID-19
Progesterone Attenuates Stress-Induced NLRP3 Inflammasome Activation and Enhances Autophagy Following Ischemic Brain Injury
Post-ischemic stroke systemic inflammation: Immunomodulation by progesterone and vitamin D hormone
Visual recovery following optic nerve crush in male and female wild-type and TRIF-deficient mice
Progesterone Treatment Attenuates Glycolytic Metabolism and Induces Senescence in Glioblastoma
Role of Toll-like receptor mediated signaling in traumatic brain injury
Vitamin D deficiency increases blood-brain barrier dysfunction after ischemic stroke in male rats
High-fructose diet during adolescent development increases neuroinflammation and depressive-like behavior without exacerbating outcomes after stroke
Repurposing and repositioning neurosteroids in the treatment of traumatic brain injury: A report from the trenches
Stress primes microglial polarization after global ischemia: Therapeutic potential of progesterone
Effect of Progesterone on Cerebral Vasospasm and Neurobehavioral Outcomes in a Rodent Model of Subarachnoid Hemorrhage
Neurobehavioral testing in subarachnoid hemorrhage: A review of methods and current findings in rodents
Progesterone treatment shows greater protection in brain vs. retina in a rat model of middle cerebral artery occlusion: Progesterone receptor levels may play an important role
Neuroprotection by progesterone after transient cerebral ischemia in stroke-prone spontaneously hypertensive rats
Progesterone improves long-term functional and histological outcomes after permanent stroke in older rats
Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials
TAK-242, an Antagonist for Toll-like Receptor 4, Protects against Acute Cerebral Ischemia/Reperfusion Injury in Mice
Progesterone treatment reduces neuroinflammation, oxidative stress and brain damage and improves long-term outcomes in a rat model of repeated mild traumatic brain injury
Vitamin D Prevents Hypoxia/Reoxygenation-Induced Blood-Brain Barrier Disruption via Vitamin D Receptor-Mediated NF-kB Signaling Pathways
Progesterone and vitamin D combination therapy modulates inflammatory response after traumatic brain injury
Recombinant tissue plasminogen activator promotes, and progesterone attenuates, microglia/macrophage M1 polarization and recruitment of microglia after MCAO stroke in rats
Suboptimal Dosing Parameters as Possible Factors in the Negative Phase III Clinical Trials of Progesterone for Traumatic Brain Injury
Combination Therapies for Traumatic Brain Injury: Retrospective Considerations
Sex-related differences in effects of progesterone following neonatal hypoxic brain injury
Prophylactic Edaravone Prevents Transient Hypoxic-Ischemic Brain Injury
The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells
Recent developments in clinical trials for the treatment of traumatic brain injury
Progesterone protects endothelial cells after cerebrovascular occlusion by decreasing MCP-1- and CXCL1-mediated macrophage infiltration
Anti-tumor effects of progesterone in human glioblastoma multiforme: Role of PI3K/Akt/mTOR signaling
Progesterone in transient ischemic stroke: a dose–response study